Welcome to the CJU website » LOG IN


Androgen replacement and/or 5 alpha reductase inhibitors in aging men
Division of Urology, University of Toronto, Sunnybrook and Women's College
Feb  2006 (Vol.  13, Issue  11, Pages( 44 - 45)


Text-Size + 

  • A case study of a typical 65 year old man with symptoms of both LUTS with established BPH, and andropause, is presented. The case for 5ARI therapy versus androgen replacement therapy is discussed, and the evidence for the use of these drugs in combination is reviewed.